Articles

KANSAS CITY, Mo., Jan 18 (Reuters) - Five years ago, Missouri dairy farmer Leroy Shatto was struggling to stay in business. Today, his herd has more than doubled amid a surge in demand for his product. The difference: a marketing campaign touting Shatto milk as free of artificial hormones.

Osborn, Missouri-based Shatto milk comes plain or flavored, but all comes from cows free of the genetically engineered hormone supplements that many conventional dairies give cows to to boost their milk production.

“That is what the consumers want now,” said Shatto, who runs a small family farm of 220 cows. “People are demanding this stuff not to be in their milk. If I had 100 more cows tomorrow, I still couldn’t keep caught up with demand.”

PICHER, Okla., April 24 (Reuters) - The death of their small town is not coming easily for the people of Picher, Oklahoma. But it is coming.

For 23 years now, the 1,500-plus residents of this historic mining community in northeast Oklahoma have known they were in trouble, trapped by growing evidence that waste from mining operations the area once thrived on was poisoning the air, the water and the land.

They have known about the lead contamination, the learning disabilities suffered by area children, the declining property values, and the cavernous holes found around the area, including one dubbed by locals as "hell's half-acre."

The golden stalks of corn and lush green soybean fields that shape the U.S. farm landscape would not normally be described as battlefields. But that’s what they are turning into as the world’s biggest agricultural technology companies wage a fight for market share of biotech corn, soybeans and other crops. And it’s about to get bloody.

Facilitated by a series of acquisitions and favourable court rulings, Dow AgroSciences, a subsidiary of Dow Chemical Co. and Syngenta Seeds, Inc., the world’s biggest agrichemicals company, are levelling a direct challenge to Monsanto Co., the acknowledged king of biotech agriculture.

Monsanto reported a higher-than-expected quarterly profit on June 30, thanks to strong sales of herbicide and genetically modified seeds.

The St. Louis company, whose shares rose to the highest level in three years, attributed the gains to an earlier-than-normal rush by producers to apply herbicides on North American farm fields, and steady growth in biotech soybeans, corn and other crops.

The company posted a 45 percent rise in net income to $252 million US, or 93 cents a share, for the fiscal third quarter ended May 31, compared with $174 million, or 66 cents, in the year-earlier quarter.

Monsanto is discussing with the American wheat industry whether it should be held to its promise not to release genetically modified wheat in the United States unless it can simultaneously market it in Canada, wheat industry officials said last week. Monsanto told top officials from U.S. wheat growing and marketing organizations that it was facing stiff opposition to its GM wheat in Canada.